BREAKING: Top U.S. Bank to Allow Consultants to Promote Bitcoin ETF
A few days ago, Bloomberg reported that Morgan Stanley will enable thousands of its financial advisors to start recommending spot Bitcoin exchange-traded funds (ETFs) to clients in the near future.
The firm has reportedly informed its 15,000 advisors that they can begin offering clients the option to invest in BlackRock Inc.’s iShares Bitcoin Trust (IBIT) or the Fidelity Wise Origin Bitcoin Fund (FBTC). Despite multiple reports, including one by CNBC, Morgan Stanley chose not to comment on the development at the time.
According to new information from multiple sources on X (Twitter), including Poloniex and Cointelegraph , the bank’s financial advisors are officially allowed to offer clients trading in Bitcoin ETFs as of today, a historic first for a major bank.
The new policy restricts offers to clients who meet certain criteria: they must have a net worth of at least $1.5 million, possess a high-risk tolerance, and be interested in speculative investments.
Morgan Stanley’s move may influence other banks that are cautious about entering the digital asset space to reconsider their stance. After the U.S. Securities and Exchange Commission approved several spot Bitcoin ETFs in January, those funds have significantly exceeded expectations in terms of assets and flows.
Disclaimer: The content of this article solely reflects the author's opinion and does not represent the platform in any capacity. This article is not intended to serve as a reference for making investment decisions.
You may also like
As global tungsten prices surge, U.S. mining company Almonty Industries (ALM.US) quickly acquires a tungsten mine in Rwanda to ease supply shortages.
U.S. mining company Almonty Industries has signed a tungsten mining agreement in Rwanda, expanding Western supply.
Novo Nordisk (NVO.US) renamed to "Novo" for a fresh start—Can multi-line breakthroughs dispel the shadow over its stock price?
Danish pharmaceutical company Novo Nordisk (NVO.US) has launched a comprehensive rebranding centered around the shorter name "Novo." The company will use "Novo" in daily brand promotion, but its legal name will remain Novo Nordisk A/S.
High interest rates are not the "end" of US stocks? Is profitability the real key?
JPMorgan believes that profit growth is the key factor determining the resilience of U.S. stock valuations. Data since 1950 shows an "inverted U-shaped" relationship between the 10-year U.S. Treasury yield and S&P 500 valuations. Based on current profit levels, yields would need to reach about 5%-6% to significantly compress valuations. As long as profit growth remains above 15%, there is still room for valuations to be re-rated. If the yield curve steepens in a bear market, cyclical sectors such as energy and financials will benefit more; if it flattens, technology stocks will have a relative advantage.
Crypto prices
More
